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TECHNICAL NOTE
Free cysteine is increased in plasma from hemodialysis patients
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Free cysteine is increased in plasma from hemodialysis patients. important role in oxidative insults, damaging cells by pro-
Background. Although only the total thiol concentration, ducing hydroxyl radicals in the course of their auto-oxida-
which includes bound and free forms, has been determined in tion. However, since reduced aminothiols usually aremost previous clinical studies, the free form may be a better
unstable, results of assays are often incorrect [6]. Specifi-predictor of cardiovascular risk.
cally, these reduced forms oxidize very rapidly in humanMethods. We measured the apparent concentration of free
homocysteine (Hcy) and cysteine (Cys) in filtered and acid- plasma [7]. Measurement of free as opposed to protein-
soluble fractions of plasma in healthy control subjects and bound forms of thiols may be a good surrogate for the
in patients with chronic renal failure just before and after a reduced form, as concentration changes for the reducedhemodialysis session.
form should parallel the changes for the free form.Results. In control, filtered Hcy and acid-soluble Hcy were
As for possible mechanisms of vascular pathogenesissimilar, while filtered Cys was much smaller than in acid-soluble
Cys. In prehemodialysis samples, filtered Cys was more than apart from oxidative stress, adverse intimal extracellular
60 times as abundant (259.2  26.2 mol/L) as in control matrix (ECM) remodeling and also disruption of some
samples (4.1  0.7 mol/L ). Free-to-total ratios for filtered intracellular processes may follow cellular uptake of un-Cys were 1.6 0.3% in controls, but 40.9 2.7% in prehemodi-
bound forms of aminothiols [8], whether reduced or inalysis patients.
the disulfide form. We, therefore, focused on the freeConclusions. The filtered fraction of thiols can be used to
estimate solute transport across the dialysis membrane. In addi- forms of aminothiols.
tion, the possible involvement of cysteine in the pathogenesis of Previous investigations attempted to determine the
atherosclerosis in hemodialysis patients should be reexamined. free forms of thiols in acid-precipitated samples (acid-
soluble fraction) [9, 10]. In estimating renal handling of
thiols or their removal by dialysis, acid precipitation is
The thiols homocysteine (Hcy) and cysteine (Cys) re- not a suitable method since acidity may affect both thiol
cently have received much attention, especially concerning binding and disulfide bonds. Acid precipitation can liber-
hyperhomocysteinemia or hypercysteinemia as an inde- ate bound thiols and other substances from proteins,
pendent risk factor for early-onset cardiovascular disease particularly albumin. In the present study, we analyzed
(CVD) in chronic renal failure patients as well as the free thiols in a fraction of plasma passing through a filter
general population [1–4]. This interest has spurred devel- used as a molecular sieve and compared free thiols in the
opment of sensitive and specific assays using a derivatiza- filtered sample to free thiols in the acid-soluble fraction.
tion agent [5]. While only total thiol concentrations, which
include both protein-bound and free forms, have been
METHODSdetermined in most previous studies, the free form may
be a better predictive index for cardiovascular events. Study patients
Cytotoxicity from oxidative stress induced by Hcy or Twenty patients undergoing maintenance hemodialy-
Cys could depend on the redox status of plasma thiol. sis (10 men, 10 women; age, 46.0  3.0 years) were
The reduced form of thiols is likely to play the more recruited for the present study. Hemodialysis was per-
formed for 4 hours three times a week using polysulfone
(BS series; Toray, Tokyo, Japan) or cellulose triacetateKey words: homocysteine, cysteine, filtered fraction, acid soluble frac-
tion, hemodialysis, atherosclerosis. membranes (FB series; Nipro, Osaka, Japan). Blood sam-
ples were collected into sterile tubes by venipuncture.Received for publication July 7, 2002
In patients undergoing hemodialysis, blood was sampledand in revised form September 6, 2002
Accepted for publication October 10, 2002 before and after hemodialysis sessions. Twenty-six healthy
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years) also were tested. All individuals gave written in- Cys, filtered Cys, and acid-soluble Cys were significantly
higher in prehemodialysis than control samples, and de-formed consent for participation in the study. Plasma
aliquots were quickly separated and frozen at 30C for creased 63.6  1.1%, 76.8  1.9%, and 49.8  3.7%,
respectively, after hemodialysis. While total Cys andanalysis by batches.
acid-soluble Cys declined to the control range, filtered
Analytical methods Cys in posthemodialysis samples was significantly greater
than in control samples.Plasma total Hcy and Cys concentrations were deter-
mined by reverse-phase high-performance liquid chro- The reduction rate for filtered Hcy or filtered Cys was
significantly larger than that for acid-soluble Hcy (P matography (HPLC) with fluorescence detection of
ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulphonate 0.049) or acid-soluble Cys (P  0.000015).
(SBD-F) thiol derivatives of Hcy and Cys using a modi-
fication of the method of Toyooka and Imai [11] with
DISCUSSION
dithioerythritol as the reducing agent.
The present study demonstrated that the unboundFree thiols were determined in both a filtered fraction
form of Cys in a filtered fraction from control plasmaand an acid-soluble fraction. Plasma samples were passed
was much smaller than estimated in previous reportsthrough a filter with a 10,000 D cutoff (ULTRACENT-
using an acid-soluble fraction. The difference in F/T ratio10; Tosoh, Tokyo, Japan) to obtain the filtered fraction.
calculated for Cys in the filtered fraction between controlThe acid-soluble fraction was obtained after protein pre-
and prehemodialysis samples also was remarkable (1.6cipitation with sulfosalicylic acid (SSA). One milliliter
0.3% vs. 40.9  2.7%), although the F/T ratio for Hcyof the plasma was mixed immediately with 0.1 mL 30%
was comparable between control and hemodialysis groups.SSA, kept at 4C for 1 hour, and centrifuged at 2500 g
This is the first report where thiols were measured inat 4C for 20 minutes. The supernatant was collected
filtered plasma fractions in control as well as hemodialy-and neutralized with NaOH. Free forms of total Hcy
sis subjects.and total Cys were measured in the filtered fraction and
All previous reports concerning the free forms of Hcyin the SSA-treated fraction (acid-soluble Hcy, acid-solu-
and Cys used the acid-soluble fraction for the determina-ble Cys). We confirmed that the pretreatment with the
tion. However the F/T ratio of Hcy and Cys varied be-filter or acid precipitation did not affect the determina-
tween reports. We speculated that this variation couldtion of these thiols using standard solution in saline.
have arisen from differences in acidifying agents and in
methods of thiol determination. However, in both thisStatistical analysis
and previous reports, the F/T ratio for acid-soluble CysResults are reported as mean  SEM. Normality of
was greater than that for acid-soluble Hcy in controldistribution was confirmed by the Kolmogorov-Smirnov
samples (36.6 1.0 vs. 8.4 1.4%) as well as prehemodi-test. Results were analyzed using Student t test for paired
alysis samples (25.2  1.4 vs. 15.8  1.0%).and unpaired data. A P value 0.05 was considered sig-
The striking difference between filtered Cys and acid-nificant. Statistics were performed on a DOS/V computer
soluble Cys in control samples shows that acid precipita-with StatView for Windows (Version 5.0, SAS institute,
tion may change the binding constant between plasmaCary, NC, USA).
proteins and thiols, liberating Cys from protein. In esti-
mating the acid-soluble fraction, one should consider
RESULTS that the acid precipitation can fail to precipitate low-
molecular-weight proteins. In considering glomerularConcentrations of total Hcy, filtered Hcy, and acid-
soluble Hcy were significantly higher in prehemodialysis filtration or solute movement across a dialysis membrane,
we presumed that acid precipitation may not be an ap-than control samples, and decreased 30.1 2.6%, 53.7
4.3%, and 38.5  4.0%, respectively, after hemodialysis. propriate method for preparing samples to determine
free thiol quantities in the estimation of solute movementHowever, total Hcy and acid-soluble Hcy posthemodial-
ysis remained higher than for controls. Posthemodialysis across the dialysis membrane.
We could not rule out of the possibility that hemodial-filtered Hcy was significantly lower than acid-soluble Hcy
(P  0.00036) (Fig. 1A). ysis patients accumulated low-molecular-weight proteins
in the plasma, which were bound with substantial amountMost strikingly, filtered Cys was very small in controls,
but was remarkably elevated in prehemodialysis samples. of thiols and leaked from the filter. However, albumin
is the most abundant protein in plasma and albumin-The free-to-total (F/T) ratio for Cys was only 1.60.3% in
controls, but was 40.9 2.7% in prehemodialysis samples. Cys34 accounts for the bulk of thiols. Therefore, it is rea-
sonable to think that filterable fractions of thiols couldThe filtered Cys concentration was significantly lower than
acid-soluble Cys in controls, but was higher than acid- be unbound form.
The ease of oxidation of Cys and Hcy results in asoluble Cys in prehemodialysis samples (Fig. 1B). Total
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Fig. 1. Homocysteine (Hcy) and cysteine (Cys) in the total (t), filtered (fl), and acid soluble (ac) fraction of plasma before hemodialysis (pre-
HD) and after hemodialysis (post-HD. (A ) shows tHcy, flHcy and acHcy, and (B ) shows tCys, flCys and acCys. In controls, flHcy and acHcy
were similar, while flCys was much smaller than in acCys. In pre-HD samples, flCys was more than 60 times as abundant as in control samples.
The T bars represent standard error.
variety of disulfide forms in vivo [12, 13], including low- mia might compete with Cys for binding sites on albumin.
The presumption might explain the difference of F/Tmolecular-weight disulfides and mixed disulfides associ-
ated with plasma protein, mainly albumin. The filterable ratio of filtered Cys before and after hemodialysis, as
well as the difference of the reduction rate of filteredfractions of thiols contain reduced-form and low-molecu-
lar-weight disulfides. In the present study, the F/T ratio Hcy and filtered Cys in the hemodialysis session.
Thiols in the filtered fraction, whether reduced or di-of filtered Cys (free Cys) in prehemodialysis samples was
significantly greater than in controls, while the F/T ratios sulfide, might be taken up into cells and disturb cellular
functions, while protein-bound forms of thiols might beof filtered Hcy in control and prehemodialysis samples
were similar (12.3  1.7% vs. 15.2  1.2%). The signifi- relatively stable. The present study demonstrated that
the filterable form of Cys was over 60 times higher incant difference of the F/T ratio between filtered Cys and
filtered Hcy (free Hcy) was also observed. We presumed hemodialysis (259.2 26.2mol/L) than in controls (4.1
0.7 mol/L ), which might be harmful to patients withthat the binding of Hcy to albumin was not affected
in the uremic plasma, but a variety of qualitatively or end-stage renal disease and relevant to the high inci-
dence of cardiovascular disease in hemodialysis.quantitatively abnormal substances accumulating in ure-
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